Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03304184 · ClinicalTrials.gov registry record · Phase 3
The Role of Biodentine in Class V Dental Lesions on Oral Health Related Quality of Life
A Phase 3 study, sponsored by University of Michigan.
- Terminated
- Registry status
- Phase 3
- Development phase
- 24
- Enrollment target
NCT03304184 is a Phase 3 study that was terminated before completion, run by University of Michigan. The registered enrollment target is 24 participants.
The verdict
NCT03304184, a Phase 3 study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 24 participants
- Enrollment target
Study Summary
The study will compare two different dental materials on dental lesions near the gum line that cause chronic pain on oral health related quality of life.
Interventions
- DEVICE Biodentine
- DEVICE Photac-fil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2017-09-28 |
| Est. Completion | 2019-10-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03304184
The ClinicalTrials.gov registry entry for NCT03304184 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Biodentine is the first listed.
NCT03304184 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03304184 about?
NCT03304184 is a clinical study titled "The Role of Biodentine in Class V Dental Lesions on Oral Health Related Quality of Life". The study will compare two different dental materials on dental lesions near the gum line that cause chronic pain on oral health related quality of life.
What is the current status of trial NCT03304184?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 24 participants. The study started on 2017-09-28. Estimated completion is 2019-10-09.
What interventions are being tested in trial NCT03304184?
The interventions under investigation include: Biodentine (DEVICE), Photac-fil (DEVICE).
Who is sponsoring clinical trial NCT03304184?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.